Skip to main
MYO
MYO logo

Myomo (MYO) Stock Forecast & Price Target

Myomo (MYO) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Myomo Inc. demonstrated impressive financial performance, reporting record total revenues of $12.1 million for the quarter, which reflects a 154% year-over-year increase and surpasses the consensus estimate of $9.9 million. The company's robust growth can be attributed to an increase in the average selling price driven by a higher number of Medicare patients, alongside a 106% year-over-year surge in total revenue units. Furthermore, the positive outlook is supported by management's guidance predicting total revenues of $50-53 million for 2025, coupled with strong operational metrics such as a gross margin increase to 71% and a significant rise in the reimbursement pipeline to 1,389 units.

Bears say

Myomo Inc. reported a decrease in its backlog of insurance-authorized orders, falling from 316 to 272, which raises concerns about future demand and revenue stability. The company faces significant risks, including balance sheet and liquidity challenges, potential failures in product safety and efficacy, issues with regulatory approvals, reimbursement difficulties, and heightened competition, all contributing to a complex risk landscape. Additionally, while a net loss of $0.01 per share was recorded, this was still a slight improvement over the anticipated consensus loss, suggesting ongoing financial difficulties that undermine investor confidence.

Myomo (MYO) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Myomo (MYO) Forecast

Analysts have given Myomo (MYO) a Strong Buy based on their latest research and market trends.

According to 8 analysts, Myomo (MYO) has a Strong Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Myomo (MYO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.